TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients

Relapse rates in surgically resected non-small-cell lung cancer (NSCLC) patients are between 30% and 45% within five years of diagnosis, which shows the clinical need to identify those patients at high risk of recurrence. The eighth TNM staging system recently refined the classification of NSCLC pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Villalba, Maria, Exposito, Francisco, Pajares, Maria Jose, Sainz, Cristina, Redrado, Miriam, Remirez, Ana, Wistuba, Ignacio, Behrens, Carmen, Jantus-Lewintre, Eloisa, Camps, Carlos, Montuenga, Luis M., Pio, Ruben, Lozano, Maria Dolores, de Andrea, Carlos, Calvo, Alfonso
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6947244/
https://ncbi.nlm.nih.gov/pubmed/31817025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8122134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados